Cargando…

Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection

BACKGROUND: Patients infected with the human immunodeficiency virus (HIV) have an increased risk of cardiovascular disease due to increased inflammation and persistent immune activation. CD163 is a macrophage scavenger receptor that is involved in monocyte-macrophage activation in HIV-infected patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beltrán, Luis M., Muñoz Hernández, Rocío, de Pablo Bernal, Rebeca S., García Morillo, José S., Egido, Jesús, Noval, Manuel Leal, Ferrando-Martinez, Sara, Blanco-Colio, Luis M., Genebat, Miguel, Villar, José R., Moreno-Luna, Rafael, Moreno, Juan Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942443/ https://www.ncbi.nlm.nih.gov/pubmed/24594990 http://dx.doi.org/10.1371/journal.pone.0090541

Ejemplares similares

Regular Training Increases sTWEAK and Its Decoy Receptor sCD163–Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
por: Schönbauer, Robert, et al.
Publicado: (2020)

Pathogenic characteristics of pulmonary infection in hospitalized patients with chronic heart failure and diagnostic value of sTREM-1, sCD163, and sTWEAK
por: Zheng, Fang
Publicado: (2022)

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis
por: Kowal-Bielecka, Otylia, et al.
Publicado: (2013)

sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
por: Comertpay, Ertan, et al.
Publicado: (2020)

The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020)

sTWEAK is a marker of early haematoma growth and leukoaraiosis in intracerebral haemorrhage
por: da Silva-Candal, Andrés, et al.
Publicado: (2021)

sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies
por: Hervella, Pablo, et al.
Publicado: (2021)

Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017)

The effect of resveratrol supplementation on the expression levels of factors associated with cellular senescence and sCD163/sTWEAK ratio in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomised clinical trial
por: Abdollahi, Shima, et al.
Publicado: (2019)

Circulating sTweak is associated with visceral adiposity and severity in patients with obstructive sleep apnea syndrome
por: Cilekar, Sule, et al.
Publicado: (2021)

Inter- Not Intraindividual Differences in sTWEAK Levels Predict Functional Deterioration and Mortality in Patients with Dilated Cardiomyopathy
por: Jarr, Kai-Uwe, et al.
Publicado: (2014)

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
por: Díaz-López, Andrés, et al.
Publicado: (2014)

Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals
por: Yadav, Anjana, et al.
Publicado: (2019)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

Reduced soluble TNF-like weak inducer of apoptosis (sTWEAK) and increased frap in postmenopausal women with metabolic syndrome
por: Comim, Fabio Vasconcellos, et al.
Publicado: (2015)

Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice
por: Sastre, Cristina, et al.
Publicado: (2014)

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases
por: Blanco-Colio, Luis M.
Publicado: (2014)

TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice
por: Fernández-Laso, Valvanera, et al.
Publicado: (2017)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects
por: Cairoli, Victoria, et al.
Publicado: (2022)

Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
por: Tarin, Carlos, et al.
Publicado: (2015)

A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
por: Méndez-Barbero, Nerea, et al.
Publicado: (2019)

The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)

Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia
por: Sanz, Ana B, et al.
Publicado: (2009)

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers
por: Dominguez-Molina, Beatriz, et al.
Publicado: (2018)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
por: Farag, Azza Gaber Antar, et al.
Publicado: (2020)

CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury
por: Akahori, Hirokuni, et al.
Publicado: (2015)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls
por: Mosepele, Mosepele, et al.
Publicado: (2017)

Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients
por: Marchetti, Giulia, et al.
Publicado: (2012)

Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance
por: Dereke, Jonatan, et al.
Publicado: (2019)

Clinical significance of sCD163 and its possible role in asthma
por: Zhi, Yue, et al.
Publicado: (2017)

TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
por: Sanz, Ana B., et al.
Publicado: (2010)

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis
por: Silva, Ricardo Luís Louzada, et al.
Publicado: (2017)

Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study
por: Feng, Lin, et al.
Publicado: (2012)

Glances in Immunology of HIV and HCV Infection
por: Quaranta, Maria Giovanna, et al.
Publicado: (2012)

Detection of Parvovirus 4 in Iranian patients with HBV, HCV, HIV mono-infection, HIV and HCV co-infection
por: Rastegarpouyani, Hosna, et al.
Publicado: (2018)

Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing
por: Mena, Alvaro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5ge6j9m93aninpuuevfa3m3mfo